Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New Pfizer antibiotic shows good activity against MRSA

April 23, 1998

New vasopressin V2 antagonists in development at Wakamoto

April 23, 1998

Sawai's beta3-agonist shows potential in diabetes Rx

April 22, 1998

New antiasthmatic presented by Pola

April 22, 1998

New beta3-agonist presented by Tokyo Tanabe

April 22, 1998

Pharmacokinetics and pharmacodynamics of IDEC-151 reported at European rhematology meeting

April 22, 1998

New antirheumatic agent shown effective in long-term patient studies

April 22, 1998

Snow Brand Milk Products isolates two new immunosuppressants

April 22, 1998

New antiparasitic agent from Kitasato Institute with a novel mechanism of action

April 22, 1998

Dainippon presents a BZP inverse agonist for the treatment of dementia

April 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.